These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7940439)

  • 21. Recurrent blisters in a case of resolving Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Chuang YN; Ho YY; Chiu TM
    Indian J Dermatol Venereol Leprol; 2014; 80(6):546-7. PubMed ID: 25382518
    [No Abstract]   [Full Text] [Related]  

  • 22. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
    Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
    Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A draft of bronchoscopic grading system in patients with toxic epidermal necrolysis.
    Lipový B; Baran M
    Burns; 2017 Jun; 43(4):890-892. PubMed ID: 28420567
    [No Abstract]   [Full Text] [Related]  

  • 24. Ocular manifestation, complications and aetiological factors in Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Chhipa SA; Masood S; Salarzai Y; Khan QA; Ahmad K; Sajid S
    J Pak Med Assoc; 2015 Jan; 65(1):62-4. PubMed ID: 25831677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toxic epidermal necrolysis.
    Lacy JA
    Nutr Clin Pract; 1991 Feb; 6(1):18-20. PubMed ID: 1775102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early tracheostomy in a case of toxic epidermal necrolysis with airways involvement.
    Vissani M; Lentischio L; Pedini G; Nicoletta G; Zava R
    Minerva Anestesiol; 2017 May; 83(5):531-533. PubMed ID: 27879956
    [No Abstract]   [Full Text] [Related]  

  • 27. Toxic epidermal necrolysis: a paradigm of critical illness.
    Estrella-Alonso A; Aramburu JA; González-Ruiz MY; Cachafeiro L; Sánchez MS; Lorente JA
    Rev Bras Ter Intensiva; 2017; 29(4):499-508. PubMed ID: 29340540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of toxic epidermal necrolysis in a 15-year-old girl.
    Clennett S; Hosking G
    J Wound Care; 2003 Apr; 12(4):151-4. PubMed ID: 12715488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica.
    East-Innis AD; Thompson DS
    West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stevens-Johnson Syndrome: A Challenging Diagnosis.
    Davis WD; Schafer PA
    Adv Emerg Nurs J; 2018; 40(3):176-182. PubMed ID: 30059372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.
    Ririe MR; Blaylock RC; Morris SE; Jung JY
    J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indications for intubation and early tracheostomy in patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Williams R; Hodge J; Ingram W
    Am J Surg; 2016 Apr; 211(4):684-688.e1. PubMed ID: 26860621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relevance and consequences of erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in gynecology.
    Niemeijer IC; van Praag MC; van Gemund N
    Arch Gynecol Obstet; 2009 Nov; 280(5):851-4. PubMed ID: 19277691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pain management in Stevens-Johnson syndrome, toxic epidermal necrolysis and other blistering diseases].
    Valeyrie-Allanore L; Ingen-Housz-Oro S; Colin A; Thuillot D; Sigal ML; Binhas M
    Ann Dermatol Venereol; 2011 Oct; 138(10):694-7; quiz 692-3, 698. PubMed ID: 21978510
    [No Abstract]   [Full Text] [Related]  

  • 35. [Stevens-Johnson syndrome and toxic epidermal necrolysis; therapy policy in these life-threatening illnesses. Netherlands Work Group Toxic Epidermal Necrolysis].
    van der Meer JB
    Ned Tijdschr Geneeskd; 1996 Jul; 140(30):1538-43. PubMed ID: 8765761
    [No Abstract]   [Full Text] [Related]  

  • 36. Endobronchial blood clots causing unilateral atelectasis with near asphyxiation.
    Cho WK; Rubinowitz AN; Siegel MD
    Clin Respir J; 2009 Apr; 3(2):112-3. PubMed ID: 20298387
    [No Abstract]   [Full Text] [Related]  

  • 37. Otologic complications of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Hotaling JM; Hotaling AJ
    Int J Pediatr Otorhinolaryngol; 2014 Aug; 78(8):1408-9. PubMed ID: 24933358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Burn Center Care of Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Cartotto R
    Clin Plast Surg; 2017 Jul; 44(3):583-595. PubMed ID: 28576247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe cutaneous adverse reactions to drugs.
    Chia FL; Leong KP
    Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):304-9. PubMed ID: 17620821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term complications of Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN): the spectrum of chronic problems in patients who survive an episode of SJS/TEN necessitates multidisciplinary follow-up.
    Lee HY; Walsh SA; Creamer D
    Br J Dermatol; 2017 Oct; 177(4):924-935. PubMed ID: 28144971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.